available

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first…

6 months ago

adidas launches RS15 Avaglide A Rugby Boot built by and for Womens Rugby Players

RS15 Avaglide is a women’s specific boot, built to support the performance requirements of athletes in modern day rugbyThe design…

6 months ago
Show previous Posts